Back to Journals » Journal of Blood Medicine » Volume 11

A Review on the Impact of Body Mass Index on Outcomes in Pediatric Leukemia

Authors Paviglianiti A

Received 26 March 2020

Accepted for publication 3 June 2020

Published 18 June 2020 Volume 2020:11 Pages 205—212

DOI https://doi.org/10.2147/JBM.S232655

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 2

Editor who approved publication: Dr Martin H Bluth


Annalisa Paviglianiti

Department of Hematology and Stem Cell Transplantation, Saint Antoine Hospital, AP-HP, Paris, France

Correspondence: Annalisa Paviglianiti
Department of Hematology and Stem Cell Transplantation, Hôpital Saint Antoine, 168 Rue du Faubourg Saint Antoine, Paris 75012, France
Tel +33(0) 1 42494823
Email annalisa.paviglianiti@gmail.com

Abstract: In the last decades, adults and pediatric obesity have become a major issue in developed countries. Considerable research has been conducted in patients with acute lymphoblastic (ALL) and myeloid leukemia (AML) with the aim of correlating body mass index (BMI) and outcomes in patients undergoing chemotherapy for hematological diseases. In adults, a high BMI has been associated with increased leukemia-related mortality. Whether a similar effect exists in the pediatric setting remains controversial. Some of the studies detailed in this review have reported no differences in outcomes according to BMI, whilst other reports have described higher treatment-related mortality, increased risk of relapse and death. Although the link between BMI and acute leukemia outcomes is controversial, a large number of studies describe poorer survival rates in children with AML or ALL with higher BMI. On the other hand, being underweight has been associated with higher treatment-related toxicity. Understanding more about the impact of BMI in pediatric leukemia is of utmost importance to provide prompt intervention and improve outcomes.

Keywords: BMI, acute leukemia, AML, ALL, HCT

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]